[go: up one dir, main page]

WO1994007480B1 - Derives de polyamine utiles comme agents anti-cytomegaloviraux - Google Patents

Derives de polyamine utiles comme agents anti-cytomegaloviraux

Info

Publication number
WO1994007480B1
WO1994007480B1 PCT/US1993/008517 US9308517W WO9407480B1 WO 1994007480 B1 WO1994007480 B1 WO 1994007480B1 US 9308517 W US9308517 W US 9308517W WO 9407480 B1 WO9407480 B1 WO 9407480B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
propyl
hydrogen
formula
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/008517
Other languages
English (en)
Other versions
WO1994007480A1 (fr
Filing date
Publication date
Priority claimed from GB929220921A external-priority patent/GB9220921D0/en
Application filed filed Critical
Priority to JP6509077A priority Critical patent/JPH08512279A/ja
Priority to AU48547/93A priority patent/AU4854793A/en
Priority to KR1019950701292A priority patent/KR950703335A/ko
Priority to EP93921461A priority patent/EP0662829A1/fr
Publication of WO1994007480A1 publication Critical patent/WO1994007480A1/fr
Publication of WO1994007480B1 publication Critical patent/WO1994007480B1/fr
Priority to NO951299A priority patent/NO951299L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Abstract

La présente invention se rapporte au traitement des infections à cytomégalovirus (CMV) à l'aide de composés de polyamine de la formule (I) dans laquelle Z représente une fraction alkylène (C2-C6) saturé ou à chaîne ramifiée; m représente 7 ou 8; chaque groupe R représente indépendamment hydrogène, un hydrocarbyle C1-C6 saturé ou insaturé, ou -(CH2)x-(Ar)-X où Ar représente phényle ou naphtyle, X représente H, alcoxy C1-C6; C1-C4 alkyle halogéné; x est un nombre entier, 0, 1 ou 2; à condition que les deux groupes R ne puissent représenter hydrogène; ou lesdits composés de la formule (I) peuvent être un sel d'addition d'acide pharmaceutiquement acceptable.
PCT/US1993/008517 1992-10-05 1993-09-10 Derives de polyamine utiles comme agents anti-cytomegaloviraux Ceased WO1994007480A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP6509077A JPH08512279A (ja) 1992-10-05 1993-09-10 抗サイトメガロウイルス剤としてのポリアミン誘導体類
AU48547/93A AU4854793A (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents
KR1019950701292A KR950703335A (ko) 1992-10-05 1993-09-10 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents)
EP93921461A EP0662829A1 (fr) 1992-10-05 1993-09-10 Derives de polyamine utiles comme agents anti-cytomegaloviraux
NO951299A NO951299L (no) 1992-10-05 1995-04-04 Polyaminderivater som anti-cytomegalovirale midler

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929220921A GB9220921D0 (en) 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents
GB9220921.2 1992-10-05

Publications (2)

Publication Number Publication Date
WO1994007480A1 WO1994007480A1 (fr) 1994-04-14
WO1994007480B1 true WO1994007480B1 (fr) 1994-05-11

Family

ID=10722983

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/008517 Ceased WO1994007480A1 (fr) 1992-10-05 1993-09-10 Derives de polyamine utiles comme agents anti-cytomegaloviraux

Country Status (9)

Country Link
EP (1) EP0662829A1 (fr)
JP (1) JPH08512279A (fr)
KR (1) KR950703335A (fr)
AU (1) AU4854793A (fr)
CA (1) CA2146319A1 (fr)
GB (1) GB9220921D0 (fr)
HU (1) HUT72663A (fr)
NZ (1) NZ256254A (fr)
WO (1) WO1994007480A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831001A (en) * 1990-10-24 1998-11-03 Allelix Biopharmaceuticals Inc. Treatment of herpesvirus infection
AU7723794A (en) * 1993-10-07 1995-05-01 Merrell Dow Pharmaceuticals Inc. Novel process for preparing polyamine derivatives and intermediates thereof
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
NZ515140A (en) 1999-04-30 2003-07-25 Slil Biomedical Corp Conformationally restricted polyamine analogs as disease therapies for cancer, epilepsy, alzheimers, infections, grafts and others
BR0010700A (pt) 1999-04-30 2002-02-13 Slil Biomedical Corp Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
AU2002235126A1 (en) 2000-11-08 2002-05-21 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
US7045550B2 (en) 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
JP2005506354A (ja) 2001-10-16 2005-03-03 スリル バイオメディカル コーポレイション 癌治療のためのオリゴアミン化合物およびその誘導体
JP7232845B2 (ja) * 2018-01-30 2023-03-03 パンベラ セラピューティクス インコーポレイテッド (6s、15s)-3,8,13,18-テトラアザイコサン-6,15-ジオールの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU628174B2 (en) * 1989-05-23 1992-09-10 Merrell Dow Pharmaceuticals Inc. A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Similar Documents

Publication Publication Date Title
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
CA2361364A1 (fr) Analogues dalda et leur utilisation
MY127946A (en) Therapeutic formulation for administering tolterodine with controlled release
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
WO1994007480B1 (fr) Derives de polyamine utiles comme agents anti-cytomegaloviraux
YU53402A (sh) Preparat
MXPA02001571A (es) Metodo de tratamiento para el cancer.
ES2163543T3 (es) Metodo para inhibir los efectos inducidos por endotoxinas.
EP0311068A3 (en) Polyamine derivatives as antineoplastic agents
EP1122252A4 (fr) Composes azotes hererocycliques condenses; procede de fabrication et agents les renfermant
IL93989A0 (en) Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
RU96103685A (ru) 1,2,5-тиадиазольные производные индолилалкил-пиридинил- и пиримидинил-пиперазинов, способ лечения или предотвращения развития сосудистой головной боли и фармацевтическая композиция
CA2441309A1 (fr) Derives de biguanide
RU95114673A (ru) Производные алкилбензоилгуанидина
PT1463504E (pt) Composicoes compreendendo epotilonas e sua utilizacao para o tratamento de sindroma carcinoide
KR950703335A (ko) 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents)
MXPA04000615A (es) Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor.
CA2478223A1 (fr) Melanges comprenant des derives d'epothilone
EP1451181A4 (fr) Composes dimeriques, et leur utilisation comme agents antiviraux
CA2501717A1 (fr) Utilisation de derives d'epothilone pour le traitement de l'hyperparathyroidie
EP0823254A4 (fr) Nouvelle utilisation de composes de pyrazolopyridine
HRP940361A2 (en) Pharmaceutical preparations for the prevention and/or treatment of gastrointestinal deseases including ulcus
RU98114985A (ru) Применение 3,4-дифенилхроманов для производства фармацевтического состава для лечения или профилактики симптомов менопаузы
RU97114098A (ru) Способ лечения рассеянного склероза
TH51768A (th) สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว